More than 200% increase in traffic to epilepsy site

Sometimes it helps to stop and take a look at your progress. Your comments on the new site have been amazing, so I was curious to know if more people are visiting the site.

I wanted to know if the changes to the site have brought more people to learn about epilepsy, and is the site helping more people with epilepsy find the resources they need. I found that the number of visitors and the number of visits has increased more than 200 percent!

Apples to Apples
I took a look at Google Analytics to see how the web traffic to the old site compared to the new site. A comparison of December 2011 (old site) to December 2012 (new site) is as close to an “Apples to Apples” comparison as I could get. Below you will see that both the number of visitors and the number of visits have more than doubled.

Dec 1, 2011 – Jan 2, 2012
539 people
672 visits

Dec 1, 2012 – Jan 2, 2013
1,221 people
1,517 Visits

Let me know what you think of the changes and don’t forget to complete the survey.

Jessica K. Smith Founder and CEO; Executive Director

Jessica Keenan Smith is a patient advocate and epilepsy community leader with more than 15 years of experience. As Founder and CEO of Living Well With Epilepsy and Executive Director of ASENT she bridges the gap between the scientific and patient communities, with a particular focus on the needs of the epilepsies. Jessica Keenan Smith is Founder and CEO of Living Well With Epilepsy, an award winning online resource for people affected by epilepsy to share stories and access in-depth information on the disease. Since 2009, Living Well With Epilepsy (https://livingwellwithepilepsy.com) has been featured in Forbes, Wired, NBC, NPR and the cover story of Epilepsy Advocate Magazine and has partnered with companies such as UCB, Lundbeck, Sunovion, Eisai, and more. Ms. Smith is also the Executive Director of the American Society for Experimental Neurotherapeutics (ASENT) (https://asent.org), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. In this role she is responsible for leading a successful scientific journal and annual scientific conference with speakers from all over the world.

See Full Bio